Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Integrative Biology : Quantitative Biosciences From Nano to Macro|October 11, 2014
Dynamic transcription factor activity and networks during ErbB2 breast oncogenesis and targeted therapyM S Weiss, B Peñalver Bernabé, S Shin, et al.
The Pharmacogenomics Journal|April 12, 2017
Prognostic impact of FOXF1 polymorphisms in gastric cancer patientsS Matsusaka, A H Wu, S Cao, et al.
The Pharmacogenomics Journal|June 1, 2016
Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancerY Sunakawa, S Cao, N B Volz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2015
Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trialsY Sunakawa, S Stintzing, S Cao, et al.
The Pharmacogenomics Journal|December 23, 2015
Genetic variants associated with colorectal brain metastases susceptibility and survivalS Stremitzer, A S Berghoff, N B Volz, et al.
ESMO Open|March 2, 2023
Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastasesJ R Hecht, S S Raman, A Chan, et al.
The Pharmacogenomics Journal|August 10, 2016
CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapyS Matsusaka, S Cao, D L Hanna, et al.
Pageof 6